MA27880A1 - Derives de tetrahydrocarbazole et leur utilisation pharmaceutique - Google Patents
Derives de tetrahydrocarbazole et leur utilisation pharmaceutiqueInfo
- Publication number
- MA27880A1 MA27880A1 MA28646A MA28646A MA27880A1 MA 27880 A1 MA27880 A1 MA 27880A1 MA 28646 A MA28646 A MA 28646A MA 28646 A MA28646 A MA 28646A MA 27880 A1 MA27880 A1 MA 27880A1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical use
- tetrahydrocarbazole derivatives
- tetrahydrocarbazole
- derivatives
- compounds
- Prior art date
Links
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical class N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000701806 Human papillomavirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47725103P | 2003-06-10 | 2003-06-10 | |
| US49782303P | 2003-08-26 | 2003-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27880A1 true MA27880A1 (fr) | 2006-05-02 |
Family
ID=33555453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28646A MA27880A1 (fr) | 2003-06-10 | 2005-12-09 | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7351733B2 (enExample) |
| EP (1) | EP1654228B1 (enExample) |
| JP (1) | JP2007501284A (enExample) |
| KR (1) | KR20060017545A (enExample) |
| AT (1) | ATE411981T1 (enExample) |
| AU (1) | AU2004247676A1 (enExample) |
| BR (1) | BRPI0411085A (enExample) |
| CA (1) | CA2528321A1 (enExample) |
| CO (1) | CO5660287A2 (enExample) |
| DE (1) | DE602004017326D1 (enExample) |
| ES (1) | ES2314446T3 (enExample) |
| IL (1) | IL171974A0 (enExample) |
| MA (1) | MA27880A1 (enExample) |
| NO (1) | NO20055741L (enExample) |
| RU (1) | RU2318810C2 (enExample) |
| WO (1) | WO2004110999A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004019541D1 (de) | 2003-08-26 | 2009-04-02 | Smithkline Beecham Corp | Cycloalkyläbü kondensierte indole |
| US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| SG184755A1 (en) | 2004-03-15 | 2012-10-30 | Ptc Therapeutics Inc | Carboline derivatives useful in the inhibition of angiogenesis |
| US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
| WO2006012310A2 (en) * | 2004-06-25 | 2006-02-02 | Genzyme Corporation | Carbazole derivatives for treating polycystic kidney disease |
| EP1824476A2 (en) * | 2004-11-22 | 2007-08-29 | SmithKline Beecham Corporation | Tetrahydrocarbazole derivatives for treating flaviridae viruses |
| JP2008520742A (ja) * | 2004-11-23 | 2008-06-19 | ピーティーシー セラピューティクス， インコーポレイテッド | Ｖｅｇｆ産生の阻害に有用なカルバゾール誘導体、カルボリン誘導体およびインドール誘導体 |
| WO2007002051A1 (en) * | 2005-06-22 | 2007-01-04 | Smithkline Beecham Corporation | Carboline derivatives and their use as inhibitors of flaviviridae infections |
| WO2013139929A1 (en) * | 2012-03-22 | 2013-09-26 | Ludwig-Maximilians-Universität München | Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging |
| JP6653573B2 (ja) | 2012-05-22 | 2020-02-26 | トラスティーズ・オブ・ダートマウス・カレッジ | シクロアルカニル［ｂ］インドール、シクロアルカニル［ｂ］ベンゾフラン、シクロアルカニル［ｂ］ベンゾチオフェンを合成するための方法、化合物および使用の方法 |
| EP2690091A1 (en) | 2012-07-25 | 2014-01-29 | Studiengesellschaft Kohle mbH | Process for preparing substituted indole derivatives |
| KR101671484B1 (ko) | 2016-07-21 | 2016-11-01 | 김정환 | 오셀타미비르(Oseltamivir)를 포함하는 인유두종 바이러스 치료용 약학적 조성물 |
| US10882821B1 (en) | 2017-09-26 | 2021-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes |
| WO2021183980A1 (en) * | 2020-03-13 | 2021-09-16 | Fmc Corporation | Substituted pyrimidines and triazines as herbicides |
| CN113995758B (zh) * | 2021-11-04 | 2023-06-02 | 中山大学 | 咔唑-嘧啶衍生物在制备治疗抗肿瘤药物中的应用 |
| KR20240075403A (ko) | 2022-11-22 | 2024-05-29 | 이경엽 | 알칼로이드 함유 인유두종 바이러스 감염의 예방 또는 치료용 조성물 |
| KR20240075422A (ko) | 2022-11-22 | 2024-05-29 | 이경엽 | 인유두종 바이러스 감염에 의한 후두유두종의 예방 또는 치료용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE507797C (de) * | 1927-05-14 | 1930-09-20 | I G Farbenindustrie Akt Ges | Verfahren zur Herstellung von 1-Aminocarbazol und seinen Derivaten |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| GB9008108D0 (en) * | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
| US5100891A (en) | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| CA2106642C (en) * | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
| JP2950433B2 (ja) * | 1995-07-10 | 1999-09-20 | インターナシヨナル・ビジネス・マシーンズ・コーポレーシヨン | バッテリ収納装置 |
| GB0015904D0 (en) * | 2000-06-28 | 2000-08-23 | Hoffmann La Roche | Inhibitors of HPV E1 helicase enzyme |
| DE10164564B4 (de) * | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR) |
| CA2468880A1 (en) * | 2001-12-14 | 2003-06-26 | Zentaris Gmbh | Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr) |
-
2004
- 2004-06-07 ES ES04776279T patent/ES2314446T3/es not_active Expired - Lifetime
- 2004-06-07 AU AU2004247676A patent/AU2004247676A1/en not_active Abandoned
- 2004-06-07 RU RU2005138124/04A patent/RU2318810C2/ru not_active IP Right Cessation
- 2004-06-07 AT AT04776279T patent/ATE411981T1/de not_active IP Right Cessation
- 2004-06-07 EP EP04776279A patent/EP1654228B1/en not_active Expired - Lifetime
- 2004-06-07 CA CA002528321A patent/CA2528321A1/en not_active Abandoned
- 2004-06-07 WO PCT/US2004/017660 patent/WO2004110999A1/en not_active Ceased
- 2004-06-07 BR BRPI0411085-4A patent/BRPI0411085A/pt not_active IP Right Cessation
- 2004-06-07 DE DE602004017326T patent/DE602004017326D1/de not_active Expired - Lifetime
- 2004-06-07 US US10/560,013 patent/US7351733B2/en not_active Expired - Fee Related
- 2004-06-07 JP JP2006533561A patent/JP2007501284A/ja active Pending
- 2004-06-07 KR KR1020057023781A patent/KR20060017545A/ko not_active Withdrawn
-
2005
- 2005-11-15 IL IL171974A patent/IL171974A0/en unknown
- 2005-12-05 NO NO20055741A patent/NO20055741L/no not_active Application Discontinuation
- 2005-12-09 MA MA28646A patent/MA27880A1/fr unknown
- 2005-12-15 CO CO05126713A patent/CO5660287A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7351733B2 (en) | 2008-04-01 |
| ATE411981T1 (de) | 2008-11-15 |
| AU2004247676A1 (en) | 2004-12-23 |
| RU2005138124A (ru) | 2006-07-10 |
| NO20055741D0 (no) | 2005-12-05 |
| WO2004110999A1 (en) | 2004-12-23 |
| EP1654228B1 (en) | 2008-10-22 |
| KR20060017545A (ko) | 2006-02-23 |
| ES2314446T3 (es) | 2009-03-16 |
| US20060161002A1 (en) | 2006-07-20 |
| DE602004017326D1 (de) | 2008-12-04 |
| BRPI0411085A (pt) | 2006-07-25 |
| RU2318810C2 (ru) | 2008-03-10 |
| IL171974A0 (en) | 2006-04-10 |
| JP2007501284A (ja) | 2007-01-25 |
| EP1654228A1 (en) | 2006-05-10 |
| NO20055741L (no) | 2006-01-06 |
| CO5660287A2 (es) | 2006-07-31 |
| CA2528321A1 (en) | 2004-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27880A1 (fr) | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique | |
| DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
| PT1206474E (pt) | Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2 | |
| EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| NO20061736L (no) | Krystallform av epotilon B | |
| EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
| ATE387435T1 (de) | Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren | |
| DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
| TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
| EA200501868A1 (ru) | ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ | |
| ATE389651T1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
| EA200601217A1 (ru) | Новые конденсированные пирролокарбазолы | |
| EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
| EA200601219A1 (ru) | Новые конденсированные пирролокарбазолы | |
| EA200401319A1 (ru) | Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине | |
| EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| SE0300457D0 (sv) | Novel compounds |